E25BIO
E25Bio specializes in the development of rapid diagnostic tests for epidemic fever viruses. It is dedicated to preventing severe downstream health outcomes with the use of mobile, fast, real-time reporting to create unprecedented large datasets to guide informed and timely responses for the control of disease spread. The company was founded in 2018 and is headquartered in Cambridge, Massachusetts.
E25BIO
Social Links:
Industry:
Biotechnology Health Care Health Diagnostics
Founded:
2018-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.e25bio.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
10.12 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Content Delivery Network Font Awesome Nginx Euro Amazon
Similar Organizations
Impact Biomedicines
Impact Biomedicines is pioneering the development of life-changing treatments for patients.
Current Employees Featured
Founder
Investors List
Small Business Innovation Research
Small Business Innovation Research investment in Grant - E25Bio
Bill & Melinda Gates Foundation
Bill & Melinda Gates Foundation investment in Grant - E25Bio
Khosla Ventures
Khosla Ventures investment in Venture Round - E25Bio
Blue Ivy Ventures
Blue Ivy Ventures investment in Venture Round - E25Bio
The Engine
The Engine investment in Seed Round - E25Bio
Alejandro Chavez
Alejandro Chavez investment in Seed Round - E25Bio
Alumni Ventures
Alumni Ventures investment in Seed Round - E25Bio
Official Site Inspections
http://www.e25bio.com
- Host name: 172.67.157.30
- IP address: 172.67.157.30
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "E25Bio"
E25Bio - Crunchbase Company Profile & Funding
E25Bio specializes in the development of rapid diagnostic tests for epidemic fever viruses. It is dedicated to preventing severe downstream health outcomes with the use of mobile, fast, real-time reporting to create unprecedented large …See details»
E25Bio Company Profile 2024: Valuation, Funding & Investors
Information on valuation, funding, cap tables, investors, and executives for E25Bio. Use the PitchBook Platform to explore the full profile.See details»
E25Bio Inc. Company Profile | Cambridge, MA - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for E25Bio Inc. of Cambridge, MA. Get the latest business insights from Dun & Bradstreet.See details»
E25Bio - Devex
Learn more about E25Bio's jobs, projects, latest news, contact information and geographical presence. Fever syndromes account for over 1 billion episodes annually and are one of the …See details»
Covid-19 diagnostic based on MIT technology might be tested
Mar 12, 2020 As more Covid-19 cases appear in the United States and around the world, the need for fast, easy-to-use diagnostic tests is becoming ever more pressing. A startup company …See details»
E25Bio - Funding, Financials, Valuation & Investors
E25Bio specializes in the development of rapid diagnostic tests for epidemic fever viruses.See details»
MIT Solve | E25Bio - Overview
What is your solution’s stage of development? Pilot: An organization deploying a tested product, service, or business model in at least one communitySee details»
E25Bio Company Profile - Office Locations, Competitors, Revenue ...
E25Bio has 5 employees at their 1 location and $4.3 m in total funding,. See insights on E25Bio including office locations, competitors, revenue, financials, executives, subsidiaries and more …See details»
E25Bio - Contacts, Employees, Board Members, Advisors & Alumni
E25Bio specializes in the development of rapid diagnostic tests for epidemic fever viruses.See details»
Biotech startup with MIT Tata Center roots produces 15-minute …
Apr 16, 2020 The startup also works with a manufacturer in India for producing similar paper-based diagnostic tests that are used to detect dengue and Zika. Bosch, who serves as …See details»
E25Bio, Inc., COVID 19 Test Kit, CEO Interview 2020
Apr 6, 2020 By January 30th, the World Health Organization deemed the current epidemic a public health emergency of international concern. That is when E25Bio decided to turn on its …See details»
E25Bio Raises $2M From Khosla Ventures To Create Rapid COVID …
Mar 18, 2020 E25Bio, a developer of rapid diagnostic tests for dangerous infectious diseases, announced this morning that it has raised a $2 million financing from storied VC firm Khosla …See details»
MIT Spinout Creates Rapid COVID-19 Diagnostic Test
Mar 17, 2020 The potential advantages of E25Bio’s COVID-19 test are that its paper test strip is low-cost, scalable, and easy to produce in mass quantities, and the testing process itself is …See details»
E25Bio Inc - Bill & Melinda Gates Foundation
To accelerate the development and launch of critical Rapid Diagnostic Tests for the detection of COVID-19 infection in order to control the current global pandemicSee details»
E25Bio Receives a Pair of Grant Awards to Expand Coronavirus and ...
Aug 13, 2020 The foundation’s grant will help E25Bio continue research and development on its rapid COVID-19 test, generate a coronavirus monoclonal antibody repository for future …See details»
E25Bio Recalls COVID-19 Tests Not Authorized by the FDA
Feb 18, 2022 E25Bio COVID-19 Direct Antigen Rapid Tests are being recalled because they are not authorized, cleared, or approved for use by the FDA.See details»
Meet the Scientist Who Built a Cheap Rapid Test in March 2020. The
Jan 3, 2022 Irene Bosch is the founder of the diagnostic company E25Bio. She’s a visiting professor at MIT, adjunct professor of medicine at Mount Sinai, New York.See details»
E25Bio has developed and preparing to bring to market a Paper …
E25Bio has developed and preparing to bring to market a Paper-based Lateral Flow Antigen Test Strip for Detecting Active COVID-19 Infection faster, simpler and cheaper than today’s Gold …See details»
Do Not Use E25Bio COVID-19 Tests: FDA Safety Communication
Feb 18, 2022 The FDA is warning people not to use the E25Bio COVID-19 Direct Antigen Rapid Test. The FDA is concerned about the risk of false results when using this test.See details»
FDA Issues Warning Regarding E25Bio COVID-19 Direct Antigen
The E25Bio COVID-19 Direct Antigen Rapid Test (DART) may also be sold under the trade name E25Bio SARS-CoV-2 Antigen Test Kit. The FDA is concerned about the risk of false results …See details»